搜尋結果
US FDA approves Neurocrine Biosciences' movement disorder drug (April 30)
Reuters· 25 分鐘前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...
Wall Street Seizes Opportunity to Gut SEC Trading Surveillance
Bloomberg· 36 分鐘前Citadel Securities is leading a suit seeking to have the SEC's Consolidated Audit Trail ...
Uber Hit With £250 Million Suit From London’s Black Cab Drivers
Bloomberg· 44 分鐘前Have a confidential tip for our reporters? Uber Technologies Inc. was sued by thousands of ...
Trump hush-money trial judge to weigh more fines for defying gag order
Reuters· 56 分鐘前The $4,000 total penalty prosecutors are seeking would come on top of a $9,000 fine Justice ...
Berkeley takes hands-off approach to Gaza campus protests. Columbia called the police
Reuters· 59 分鐘前At Columbia University, tensions between the administration and students protesting over ...
Blood Tests for Wegovy? Diagnostic Companies Target GLP-1s
Bloomberg· 1 小時前Companies that make diagnostic tests are targeting the ever-growing population of GLP-1 users. ...
CCTV Digital Script 29/04/24
CNBC· 1 小時前— This is the digital script of CNBC's news report for China's CCTV on April 29, 2024. According to the financial website ...
Low turnout, apathy in India election a worry for Modi's campaign
Reuters· 2 小時前A lower turnout so far in India’s long general election has rattled Prime Minister Narendra ...
Palestinian security force kills Islamic Jihad gunman in rare internal clash
Reuters· 2 小時前Palestinian security officers killed a gunman in the occupied West Bank on Thursday, a rare intra-Palestinian clash whose ...
Sustainable living offers hope for future for Hungarian families
Reuters· 3 小時前Kemencei says while becoming fully self-sufficient seems an unrealistic goal, they rely ...